Electrotherapy Devices (TENS, EMS) in Connecticut

CEFALY Technology manufactures FDA-cleared wearable neuromodulation devices for the acute treatment and prevention of migraine headaches. The CEFALY device is a transcutaneous electrical nerve stimulation (TENS) system that targets supraorbital nerve pathways to reduce migraine pain and frequency without pharmaceutical intervention. The company positions its products as drug-free alternatives for migraine management, with clinical evidence demonstrating reduction in migraine days and decreased reliance on migraine medications. The device operates through two treatment modes: an ACUTE program for rapid pain relief during active migraine attacks, and a PREVENT program (20-minute daily protocol) for long-term migraine frequency reduction. CEFALY offers connected device options integrated with the CeCe Migraine Management mobile application (iOS and Android), enabling patients to track treatments, identify migraine patterns, and optimize therapy protocols. The product has been in clinical use since 2008 and is relied upon by tens of thousands of patients. The company emphasizes safety and tolerability, with no serious adverse effects reported and a 90-day money-back guarantee. Distribution is direct-to-consumer via the company website with flexible payment options including Affirm financing, PayPal Credit, and HSA/FSA eligibility. CEFALY maintains regulatory clearance through FDA approval and positions its neuromodulation technology as addressing medication overuse headache (MOH) concerns and cognitive side effects associated with traditional migraine pharmaceuticals.

BioWave Corporation manufactures FDA-cleared neuromodulation devices for non-invasive pain management and functional recovery. The company specializes in high-frequency peripheral nerve stimulation (HFPNS) technology that delivers therapeutic stimulation directly to pain nerves, blocking pain signal transmission at the source rather than masking surface pain. BioWave's product line includes portable, easy-to-use devices for clinical and home use, complemented by professional in-office procedures. Products include BioWavePRO (professional clinical system), BioWaveHOME (home-use device), BioWaveGO (portable system), BioWavePENS (in-office procedure delivering up to 72 hours of relief in a 30-minute session), and consumable electrodes (noninvasive and percutaneous). Clinical evidence demonstrates meaningful pain reduction, improved mobility and activities of daily living, reduced medication dependency, and high patient satisfaction. The technology is prescribed by the Veterans Administration for tens of thousands of veterans managing chronic and acute pain. BioWave devices are indicated for use in orthopedic, sports medicine, workers' compensation, personal injury, and auto insurance settings. The company serves patients, healthcare providers, sports medicine teams, and distribution partners. Devices are non-surgical, drug-free, and safe for continuous home use with automatic shut-off. Coverage is available through multiple insurance pathways including Workers' Compensation and Personal Injury claims.

TrumedX LLC is a durable medical equipment manufacturer and distributor specializing in post-operative and injury recovery solutions. The company manufactures four primary product lines: cold compression therapy (CCT) systems for swelling and pain reduction, electrical muscle stimulation (EMS) devices for targeted muscle strength restoration, orthopedic bracing products for joint support and stabilization, and deep vein thrombosis (DVT) prevention devices for blood clot prophylaxis during recovery periods. These devices are marketed to both clinical and homecare settings, targeting patients recovering from injury or surgery who require non-pharmacological pain management and functional support. The product portfolio addresses common post-operative complications and pain management needs in rehabilitation and physical therapy contexts. TrumedX operates a distributor network model, actively recruiting partners to expand market reach. The company positions itself as a provider of evidence-based recovery solutions with a focus on enabling faster return to normal daily activities and reducing recovery duration through evidence-supported modalities.